Connection
Joshua Klopper to Biopsy, Fine-Needle
This is a "connection" page, showing publications Joshua Klopper has written about Biopsy, Fine-Needle.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.369 |
|
|
|
-
Barrett TF, Jama M, Alshalalfa M, Tharakan T, Hao Y, Klopper JP, Cavazos TB, Jackson RS, Pipkorn P, Rich JT, Zolkind PA, Adkins DR, Oppelt P, Apicelli AJ, Rammohan N, Brown TC, Puram SV, Jasim S, Harbison RA. Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor Risk. Otolaryngol Head Neck Surg. 2026 Sep; 175(3):578-586.
Score: 0.059
-
Castellanos LE, Bryan J, Ricarte-Filho JC, Franco AT, Alshalalfa M, Klopper JP, Kloos RT, Waguespack SG. Afirma genomic sequencing classifier performance in young patients with cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2026 Jun 17; 111(7):1920-1926.
Score: 0.059
-
Nasr CE, Andrioli M, Endo M, Harrell RM, Livhits MJ, Osakwe I, Polavarapu P, Siperstein A, Wei S, Zheng X, Jiang R, Hao Y, Huang JIN, Klopper JP, Kloos RT, Kennedy G, Angell TE. Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis. J Clin Endocrinol Metab. 2023 05 17; 108(6):1526-1532.
Score: 0.047
-
Patel J, Klopper J, Cottrill EE. Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities. Front Endocrinol (Lausanne). 2023; 14:1101410.
Score: 0.047
-
Randolph GW, Sosa JA, Hao Y, Angell TE, Shonka DC, LiVolsi VA, Ladenson PW, Blevins TC, Duh QY, Ghossein R, Harrell M, Patel KN, Shanik MH, Traweek ST, Walsh PS, Yeh MW, Abdelhamid Ahmed AH, Ho AS, Wong RJ, Klopper JP, Huang J, Kennedy GC, Kloos RT, Sadow PM. Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier. Thyroid. 2022 09; 32(9):1069-1076.
Score: 0.045
-
Urken ML, Milas M, Randolph GW, Tufano R, Bergman D, Bernet V, Brett EM, Brierley JD, Cobin R, Doherty G, Klopper J, Lee S, Machac J, Mechanick JI, Orloff LA, Ross D, Smallridge RC, Terris DJ, Clain JB, Tuttle M. Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative. Head Neck. 2015 Apr; 37(4):605-14.
Score: 0.025
-
Alexander EK, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, Parker C, Steward DL, Mandel SJ, Haugen BR. Multicenter clinical experience with the Afirma gene expression classifier. J Clin Endocrinol Metab. 2014 Jan; 99(1):119-25.
Score: 0.025
-
Duick DS, Klopper JP, Diggans JC, Friedman L, Kennedy GC, Lanman RB, McIver B. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology. Thyroid. 2012 Oct; 22(10):996-1001.
Score: 0.022
-
French JD, Kotnis GR, Said S, Raeburn CD, McIntyre RC, Klopper JP, Haugen BR. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J Clin Endocrinol Metab. 2012 Jun; 97(6):E934-43.
Score: 0.022
-
Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009 Jun; 94(6):2092-8.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|